
0.8801 Delayed Data As of Jan 27 | ![]() Today’s Change | 0.53 Today|||52-Week Range 3.99 | +31.95% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $12.3M |
Cyclacel Pharmaceuticals, Inc. 200 Connell Drive Berkeley Heights New Jersey 07922 |
Spiro Rombotis | President, Chief Executive Officer & Director |
Paul McBarron | Secretary, Chief Operating & Financial Officer |
Mark Kirschbaum | Chief Medical Officer & Senior Vice President |